The cell undergoes a diverse range of stimulations including growth factor activation and signal transduction from adhesion receptors, such as cadherins. In the absence ofa mitogenic signal from outside the cell, P catenin is sequestered in complexes with the product of the adenomatous polyposis coli (APC) gene and a serine threonine glycogen kinase (GSK 30) enabling degradation of free P catenin.
Epithelial tissues are constantly adapting to physiological stimuli in the surrounding environment by proliferation, differentiation, apoptosis, and cell migration.' These processes are pre-programmed temporally in the genome but they are also under the influence of several signal transduction pathways initiated by contact with adjacent cells in the immediate microenvironment. In particular, the cell is under diverse stimuli including growth factor activation and signal transduction from adhesion receptors, such as cadherins. Perturbation of the balance between these mechanisms may play a role in early tumorigenesis and one of the key molecules involved in modulating this process is P catenin.2A In particular, 13 catenin modulation may explain how mutations of the adenomatous polyposis coli (APC) gene initiate the formation of adenomas that can develop into fatal carcinomas.
In the absence of a mitogenic signal from outside the cell, ,B catenin is sequestered in complexes with the APC gene product and a serine threonine glycogen kinase (GSK 313), enabling degradation of free 1 catenin.R esidual catenins hold cells together by binding to cadherins both at adherens junctions and the actin cytoskeleton (fig 1) . When a mitotic signal is delivered by the wnt pathway, GSK 313 is antagonised so that 1 catenin can no longer be degraded. Cytosolic concentrations rise and binding to other newly synthesised proteins occurs, especially transcription factors that are transported to the nucleus, such as lymphocyte enhancing factor (LEF) and T cell factor (Tcf-4).
These interacting signalling pathways are important in embryogenesis, especially epithelio-mesenchymal transition, and in epithelial tumorigenesis. In this regard, the wnt-1 gene product is required for normal development of the mammalian central nervous system but can also contribute to mammary oncogenesis when expressed inappropriately in the mammary gland or in cell lines in vitro.7 Furthermore, work on Xenopus laevis and Drosophila melanogaster embryos provided new insights, as early as the gastrulation stage of development.8 1 catenin in the nucleus binds either to LEF-1 or Tcf-4 transcription factors and acts as a cofactor to regulate the transcription of genes, thereby allowing catenin regulated transcription.
It is now known that this residual free monomeric 1 catenin binds to the high mobility group domain (HMG) of the two transcription This model is compelling because it also explains the apparent differences between certain APC mutations, especially those with mutations of the catenin binding domains, which are associated with the most aggressive cell phenotype. The phenotype and invasive potential of these transformed cells can be influenced further by destabilisation of the adherens junctions, such as occurs commonly as a result of cadherin mutation. Moreover, it supports the current theory that invasion not only requires a transformed genotype involving Ki-ras mutations, p53 mutations, bcl-2 overexpression, and microsatellite or chromosomal instability,'2 13 but also loss of inhibitory environmental cues from the crypt microenvironment, such as altered adhesion and mitogenesis.
These changes in catenin and APC biology may not transform cells fully but they appear to be a necessary final common pathway for several cancers of the mucous secreting crypts (colorectal cancer) or melanoma before invasion. The assessment of catenin or APC mutations in surveillance programmes represents an important tool by which to stratify risk in patients at risk for cancer.
In conclusion, small differences in specific combination, concentrations, function, and distribution of catenins (and cadherins) are present in each cell type and can dictate a specific "embryonic" or cancer phenotype. '4 
